Justia U.S. Federal Circuit Court of Appeals Opinion Summaries

by
Chamberlain’s 611 patent, entitled “Barrier Movement Operator Human Interface Method and Apparatus,” is directed to improved methods of human interaction with “barrier movement operators,” such as garage door operator systems. Claims 18–25 of the patent are directed to an “interactive learn mode” that “guide[s] a user through installation and learn mode actions.” On inter partes review, the Patent Trial and Appeal Board found those claims anticipated, 35 U.S.C. 102(b) and 103(a). The Federal Circuit affirmed the findings as supported by substantial evidence. The disclosure, in prior art, of transmitting the signals in sequence, one after the other in response to the previously-completed steps of identifying the garage door operator’s present status and activities to be completed teaches the “responsive to” step in the challenged claim. View "Chamberlain Group, Inc. v. One World Technologies, Inc." on Justia Law

by
Amgen’s patents relate to erythropoietin (EPO) isoforms and aspects of their production. EPO is a glycoprotein hormone that regulates red blood cell maturation and production. Recombinant human EPO is an important therapeutic protein for the treatment of anemia. Amgen manufactures and markets recombinant human EPO as Epogen. Hospira submitted its Biologics License Application (BLA) to the FDA, seeking approval for a biosimilar to Amgen’s Epogen product. Amgen sued Hospira for infringement under 35 U.S.C. 271(a) and 271(e)(2)(C). A jury found the asserted claims not invalid and infringed. Of the 21 accused drug substance batches, the jury found seven batches entitled to the Safe Harbor defense. The jury awarded Amgen $70 million in damages. The Federal Circuit affirmed, upholding the district court’s claim construction and finding substantial evidence of infringement. Section 271(e)(1) carves out a "Safe Harbor” exception to patent infringement liability when otherwise-infringing activities are solely for uses reasonably related to obtaining FDA approval. Substantial evidence supports the jury’s finding that the 14 batches at issue were not manufactured “solely for uses reasonably related to the development and submission of information” to the FDA. View "Amgen Inc. v. Hospira, Inc." on Justia Law

by
Blackbird sued HIM for infringement of a patent relating to exercise equipment. Blackbird is owned and controlled entirely by attorneys, whose business model consists of purchasing patents and monetizing them “through litigation.” Nineteen months later, after a transfer of venue, Blackbird offered to settle for $80,000. HIM declined, asserting that the infringement allegations lacked merit and that HIM believed there was a strong likelihood that Blackbird would be ordered to pay attorney fees. Blackbird made another t offer, for $50,000. Again, HIM declined. Months later, Blackbird offered to settle for $15,000. HIM declined, again requesting that Blackbird pay some of its expenses. Blackbird then offered a “walk-away” settlement whereby HIM would receive a license to Blackbird’s patent for zero dollars, and the case would be dismissed. HIM declined. During discovery, HIM moved for summary judgment. After the motion was briefed and without notifying HIM in advance, Blackbird filed a notice of voluntary dismissal with prejudice, executed a covenant not to sue, and moved to dismiss for lack of subject matter jurisdiction. The district court dismissed Blackbird’s claims with prejudice, denied Blackbird’s motion to dismiss, and authorized HIM to seek costs, expenses, and attorney fees. The Federal Circuit affirmed an award to HIM of fees and expenses in the requested amount ($363,243.80), upholding findings that Blackbird’s litigation position was “meritless” and “frivolous.” Blackbird litigated in an unreasonable manner and the court properly considered the need to deter future abusive litigation. View "Blackbird Tech LLC v. Health in Motion, LLC" on Justia Law

by
Chamberlain's patent discloses improved “movable barrier operators,” such as garage door openers. The patent describes a need for “a passive infrared detector for controlling illumination from a garage door operator which could be quickly and easily retrofitted to existing garage door operators” and discloses as its invention “a passive infrared detector for a garage door operator,” contained in a wall control unit, along with an ambient light comparator and a microcontroller. The International Trade Commission determined, 19 U.S.C. 1337, that the Appellants’ importation of garage door opener products infringed the patent and entered limited exclusion orders and cease and desist orders. The Federal Circuit vacated the orders, concluding that the Commission erred in its construction of “wall console,” a term in each of the patent claims. Although claim terms are normally given their ordinary and customary meaning, as understood by persons of ordinary skill in the art in view of the specification and prosecution history, Chamberlain disavowed coverage of wall consoles without a passive infrared detector. The term is properly construed as a “wall-mounted control unit including a passive infrared detector.” The parties agree that the Appellants do not infringe the patent under that construction. View "Techtronic Industries Co. Ltd. v. International Trade Commission" on Justia Law

by
Ericsson owns patents essential to practicing standards (SEPs) that enable mobile devices from different manufacturers and different networks to communicate with each other using the same communication protocol. Ericsson is a member of the European Telecommunications Standards Institute (ETSI), the organization responsible for developing 2G, 3G, and 4G standards. ETSI’s acceptance of a member’s patent as "SEP" forms a contract between ETSI and its members. SEP owners wield significant power over implementers during licensing negotiations, so the ETSI contract imposes an obligation to license (FRAND obligation). Ericsson and TCL have been negotiating licensing terms for over a decade. There was litigation. The parties agreed to binding court adjudication of terms for a worldwide portfolio license. The district court imposed a prospective FRAND royalty rate for practicing each standard, and a “release payment” computed based on a closely related, retrospective FRAND rate for “TCL’s past unlicensed sales.” The court rejected both parties’ proposed methodologies and employed its own modified version of TCL’s proposed “top-down” approach in combination with comparable license evidence to compute both the prospective and retrospective FRAND rates. The Federal Circuit vacated in part. Ericsson had a Seventh Amendment right to a jury trial on the adjudication of the “release payment” term; the release payment is in substance compensatory relief for TCL’s past patent infringing activity. View "TCL Communication Technology Holdings Ltc. v. Telefonaktiebolaget LM Ericsson" on Justia Law

by
Following a 2019 Federal Circuit decision and enactment of the Blue Water Navy Vietnam Veterans Act of 2019 133 Stat. 966, the petitioners, who served on open sea ships off the Vietnamese shore during the Vietnam War believed that they may be entitled to a presumption of service connection for diseases covered by 38 U.S.C. 1116. The Secretary of Veterans Affairs stayed pending disability compensation claims until January 1, 2020. Petitioners assert that many Blue Water Veterans are dying and filed a petition for expedited review under 38 U.S.C. 502 challenging the Secretary’s authority to stay pending disability compensation claims. The Federal Circuit denied the petition. The court concluded that it had jurisdiction 5 U.S.C. 552(a)(1)(D) because the Secretary’s memorandum amounts to an “interpretation[] of general applicability formulated and adopted by the agency.” The Act unambiguously authorizes the Secretary to stay disability compensation claims described in section 2(c)(3)(B) of the Act “until the date on which the Secretary commences the implementation of [] section 1116A,” 133 Stat. at 968. View "Procopio v. Secretary of Veterans Affairs" on Justia Law

by
McCord injured his back while serving in the Army and was discharged with a 20% disability rating. Because his rating was below 30% and he served for less than 20 years, McCord received severance pay instead of ongoing military retirement pay and received monthly VA benefits. The Army Board for Correction of Military Records later corrected his record to reflect a 30% disability rating and entitlement to medical retirement pay, rather than severance pay. McCord later challenged the government’s calculation of his entitlement to military retirement back pay and its claimed right to recover the severance pay and requested damages for medical expenses that he incurred because he was not afforded TRICARE coverage before the correction. The Claims Court rejected McCord’s approach to back pay calculation as “double-dipping,” denied relief regarding the recoupment of severance pay “as not ripe,” and held that McCord failed to exhaust administrative procedures for securing TRICARE benefits. The Federal Circuit affirmed except as to the out-of-pocket medical expenses. The court cited 10 U.S.C. 1201, 1203, 1212(d)(a), and 2774, as defining entitlement to retirement pay or severance pay, VA benefits, and the circumstances for recoupment of severance pay. A veteran receiving VA benefits may face a disadvantage if he also secures an award of military retirement pay because he would not be entitled to severance pay but military retirement pay includes TRICARE coverage. View "McCord v. United States" on Justia Law

by
Omnium sued Donghee, asserting infringement of eight patents, including the 921 and 812 patents, which generally relate to manufacturing plastic fuel tanks formed by blow molding. The fuel tanks are formed in a way that allows accessory components to be installed inside the fuel tank without cutting holes in the tank wall, which could compromise the structural integrity of the wall. The parties disputed the meaning of the term “parison.” Donghee argued that it should be given its plain and ordinary meaning of “hollow plastic tube exiting the die of an extrusion head.” Omnium argued that the patentee had acted as its own lexicographer and that the patents do not use the term in its conventional, ordinary meaning. The district court reasoned that “the patents specify that the ‘parison’ is cut in two as it leaves the die at the end of the extrusion head” and so “this ‘parison’ cannot be strictly limited to a fully-formed tubular structure existing in its entirety outside the extrusion head/die.” It recognized that “the principal disagreements between the parties [were] identifying the point at which the molten plastic within the extrusion head becomes a ‘parison.’ The Federal Circuit affirmed summary judgment of noninfringement, upholding the claim construction as supported by undisputed facts. View "Plastic Omnium Advanced Innovation and Research v. Donghee America, Inc." on Justia Law

by
The Landowners filed a “rails-to-trails” class action against the United States, claiming that the government, through the National Trails System Act, effected a Fifth Amendment taking of Landowners’ reversionary rights to property underlying railroad easements owned by the BNSF Railway. On remand, the Claims Court rejected the government’s argument that a negotiated settlement had been abandoned; approved that settlement agreement as procedurally and substantively fair; entered a partial final judgment pursuant to Rule 54(b) “in the total amount of $159,636,521.65, consisting of $110,000,000 in principal and $49,636,521.65 in interest,” and deferred determination on the amount of attorney fees and costs to award class counsel under the Uniform Relocation Assistance and Real Property Acquisition Policies Act of 1970 (URA). The Federal Circuit affirmed, upholding finding that the government failed to meet “its burden of demonstrating that the parties unequivocally intended to abandon the Settlement Agreement.” The court declined to address the government’s argument that the Claims Court erred by not limiting class counsel to the agreed amount of URA fees and costs, concluding that it lacked jurisdiction over the issue. View "Haggart v. United States" on Justia Law

by
In 1980, Langkamp, then a toddler, suffered severe burn injuries on U.S. Army property. In a suit under the Federal Tort Claims Act, the parties entered into a Settlement Agreement. The government agreed to pay $239,425.45 upfront to cover attorney fees and costs, plus a structured settlement: $350.00 per month, 1985-1996; $3,100.00 per month, guaranteed for 15 years, beginning in 1996, and Lump Sum Payments of $15,000.00 in 1996, $50,000.00 in 2000, $100,000.00 in 2008, 250,000.00 in 2018, and $1,000,000.00 in 2028. The government issued a check for $239,425.45 to the parents and a check for $160,574.55 payable to JMW Settlements, an annuity broker. JMW purchased two single-premium annuity policies from ELNY to fund the monthly and periodic lump-sum payments. Until 2013, ELNY sent Langkamp the specified monthly and periodic lump-sum payments. Following ELNY’s insolvency and court-approved restructuring, Langkamp’s structured settlement payments were reduced to 40 percent of the original amount. The Claims Court rejected Langkamp’s argument that the government had continuing liability for the Settlement Agreement payments. The Federal Circuit reversed. The Settlement Agreement contains no reference to the purchase of an annuity from a third party but unambiguously obligates the government to ensure that all future monthly and periodic lump-sum payments are properly disbursed. The court noted that in 1984 it cost the government approximately $160,000 to obtain a promise from an insurance company to fund the future payments specified in the Settlement Agreement. View "Langkamp v. United States" on Justia Law